Contact
searchSearch
HMP Global

Heartburn

Featured Article

Quiz
Recommended Dosage of an H2 Blocker for Gastroesophageal Reflux Disease
11/18/2022
Maria Asimopoulos
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage...
11/18/2022
Pharmacy Learning Network
News
Vonoprazan vs Esomeprazole for Treating Symptomatic Gastroesophageal Reflux Disease
11/14/2022
Maria Asimopoulos
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the...
11/14/2022
Pharmacy Learning Network
Poll
Recommending Over-the-Counter Medications for Heartburn
10/25/2022
Maria Asimopoulos
Of the following over-the-counter medications, which therapy are you most likely to recommend to patients with heartburn?
Of the following over-the-counter medications, which therapy are you most likely to recommend to patients with heartburn?
Of the following...
10/25/2022
Pharmacy Learning Network
News
Adding Dopamine Antagonist to PPI Therapy for GERD
10/18/2022
Jolynn Tumolo
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line...
10/18/2022
Pharmacy Learning Network
Quiz
Identifying Preferred H2 Blocker for Treating GERD in Breastfeeding Patients
09/26/2022
Maria Asimopoulos
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor...
09/26/2022
Pharmacy Learning Network
News
Vonoprazan vs PPIs for Treating Heartburn in Patients With Erosive Esophagitis
09/13/2022
Maria Asimopoulos
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and...
09/13/2022
Pharmacy Learning Network
News
Heartburn Center Successfully Centralizes Care in a Community Setting
12/22/2021
Jolynn Tumolo
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive...
12/22/2021
Pharmacy Learning Network
Quiz
Understanding Overnight Symptoms of Heartburn
12/22/2021
Maria Asimopoulos
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have...
12/22/2021
Pharmacy Learning Network
Quiz
Preventing Symptoms of Heartburn
12/22/2021
Maria Asimopoulos
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food...
12/22/2021
Pharmacy Learning Network
News
Proton Pump Inhibitors May Reduce Severity of Gum Disease
11/08/2021
Jolynn Tumolo
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs)...
11/08/2021
Pharmacy Learning Network
Quiz
Identifying Active Ingredients for Treating Heartburn
10/16/2021
Maria Asimopoulos
What kind of active ingredient is famotidine?
What kind of active ingredient is famotidine?
What kind of active ingredient...
10/16/2021
Pharmacy Learning Network

Newsfeed

News
Vonoprazan vs Esomeprazole for Treating Symptomatic Gastroesophageal Reflux Disease
11/14/2022
Maria Asimopoulos
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the efficacy and safety of vonoprazan and esomeprazole in patients with gastroesophageal reflux disease who responded only partially to proton pump inhibitors.
Investigators compared the...
11/14/2022
Pharmacy Learning Network
News
Adding Dopamine Antagonist to PPI Therapy for GERD
10/18/2022
Jolynn Tumolo
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line medications for GERD, up to one-third of patients do not experience symptom relief after an 8-week course of PPI therapy," researchers said.
“Although PPIs are first-line...
10/18/2022
Pharmacy Learning Network
News
Vonoprazan vs PPIs for Treating Heartburn in Patients With Erosive Esophagitis
09/13/2022
Maria Asimopoulos
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and meta-analysis, researchers compared the efficacy of vonoprazan and proton pump inhibitors for resolving heartburn in patients with erosive esophagitis.
In a systematic review and...
09/13/2022
Pharmacy Learning Network
News
Heartburn Center Successfully Centralizes Care in a Community Setting
12/22/2021
Jolynn Tumolo
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive heartburn center in a community setting was commercially viable and boosted patient satisfaction, according to recent findings.
Integrating a comprehensive...
12/22/2021
Pharmacy Learning Network
News
Proton Pump Inhibitors May Reduce Severity of Gum Disease
11/08/2021
Jolynn Tumolo
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid-related gastrointestinal disorders,” researchers explained. “PPIs could potentially be used in combination with other periodontal treatments."
“Proton pump inhibitors (PPIs)...
11/08/2021
Pharmacy Learning Network
News
Research Identifies OTC Meds Commonly Involved in Drug-Drug Interactions
10/08/2021
Jolynn Tumolo
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,”...
10/08/2021
Pharmacy Learning Network
News
Pharmacist Intervention Improved PPI Use Among Patients With Heartburn, Other Acid-related Disorders
09/23/2021
Jolynn Tumolo
“In a busy inpatient setting, we developed a feasible way to assess PPI therapy, deimplement nonguideline-concordant PPI use, and provide follow-up to assess any unintended consequences,” explained researchers.
“In a busy inpatient setting, we developed a feasible way to assess PPI therapy, deimplement nonguideline-concordant PPI use, and provide follow-up to assess any unintended consequences,” explained researchers.
“In a busy inpatient setting, we...
09/23/2021
Pharmacy Learning Network
News
Prescription-Strength Heartburn Drug Recalled
11/13/2020
A Class II recall is active for a prescription proton-pump inhibitor that treats stomach ulcers, gastroesophageal reflux disease, and high levels of stomach acid.
A Class II recall is active for a prescription proton-pump inhibitor that treats stomach ulcers, gastroesophageal reflux disease, and high levels of stomach acid.
A Class II recall is active for...
11/13/2020
Pharmacy Learning Network
News
OTC Heartburn Medication Recalled
12/13/2019
Sanofi-Aventis US issued a precautionary, voluntarily recall of all over-the-counter Zantac (ranitidine) products because of possible contamination with NDMA.
Sanofi-Aventis US issued a precautionary, voluntarily recall of all over-the-counter Zantac (ranitidine) products because of possible contamination with NDMA.
Sanofi-Aventis US issued a...
12/13/2019
Pharmacy Learning Network
News
Heartburn Drug Recalled
11/08/2019
The FDA is recalling nearly 70,000 bottles of an antacid and antihistamine used to treat heartburn, stomach ulcers, and gastroesophageal reflux disease.
The FDA is recalling nearly 70,000 bottles of an antacid and antihistamine used to treat heartburn, stomach ulcers, and gastroesophageal reflux disease.
The FDA is recalling nearly...
11/08/2019
Pharmacy Learning Network
News
Olanzapine Tablets Recalled Due to Failed Impurities Specifications
10/01/2026
Rebecca Amrick
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a voluntary Class III recall after the product failed to meet impurities specifications, affecting 22 032 bottles.
Olanzapine tablets are under a...
10/01/2026
Pharmacy Learning Network
News
Menow Sunscreen Pressed Powder Recalled Due to CGMP Deviations
10/01/2026
Rebecca Amrick
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has been issued for Menow sunscreen pressed powder due to Current Good Manufacturing Practice (CGMP) deviations, a discrepancy that affects 2970 units.
A voluntary Class II recall has...
10/01/2026
Pharmacy Learning Network
News
Exenatide Injection Recalled Due to Defective Delivery System
10/01/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug Administration (FDA) has issued a Class II recall for exenatide injection due to a defective drug delivery system, affecting 5694 pens.
The US Food and Drug...
10/01/2026
Pharmacy Learning Network
PharmLaw
Florida Attorney General Sues Insulin Manufacturers, PBMs Over Alleged Pricing Scheme
09/30/2026
Grace Taylor, MS, MA
Florida is challenging insulin manufacturer and pharmacy benefit manager (PBM) rebate and formulary arrangements that the state alleges contributed to higher insulin costs and restricted competition.
Florida is challenging insulin manufacturer and pharmacy benefit manager (PBM) rebate and formulary arrangements that the state alleges contributed to higher insulin costs and restricted competition.
Florida is challenging insulin...
09/30/2026
Pharmacy Learning Network
News
Dopamine Hydrochloride Injection Recalled Due to Lack of Sterility Assurance
09/24/2026
Rebecca Amrick
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection is under a voluntary Class II recall due to the product’s lack of sterility assurance.
Dopamine hydrochloride injection...
09/24/2026
Pharmacy Learning Network
News
Chlorthalidone Tablets Recalled Due to Failed Dissolution Specifications
09/24/2026
Rebecca Amrick
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has been issued for chlorthalidone tablets after the product failed to meet dissolution specifications, a discrepancy that affects 13 567 bottles.
A voluntary Class II recall has...
09/24/2026
Pharmacy Learning Network
News
Thyroid Tablets Recalled Due to Drug Superpotency
09/24/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug Administration (FDA) has issued a Class I recall for thyroid tablets due to drug superpotency, affecting 1955 bottles.
The US Food and Drug...
09/24/2026
Pharmacy Learning Network
PharmLaw
Express Scripts Faces Lawsuit Over Arkansas Pharmacy Reimbursement Rates
09/23/2026
Grace Taylor, MS, MA
Arkansas pharmacies allege Express Scripts violated state law by reimbursing prescription claims below required rates.
Arkansas pharmacies allege Express Scripts violated state law by reimbursing prescription claims below required rates.
Arkansas pharmacies allege...
09/23/2026
Pharmacy Learning Network
News
Povidone and Proparacaine Ophthalmic Solution Recalled Due to Drug Subpotency
09/17/2026
Rebecca Amrick
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine hydrochloride ophthalmic solution is under a voluntary Class III recall due to drug subpotency, affecting 772 bottles.
Povidone iodine and proparacaine...
09/17/2026
Pharmacy Learning Network
News
Fluphenazine Hydrochloride Tablets Recalled Due to Failed Impurities Specifications
09/17/2026
Rebecca Amrick
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has been issued for fluphenazine hydrochloride tablets after the product failed to meet impurities specifications, a discrepancy that affects 403 200 tablets.
A voluntary Class III recall has...
09/17/2026
Pharmacy Learning Network

Quiz Series

Quiz
Recommended Dosage of an H2 Blocker for Gastroesophageal Reflux Disease
11/18/2022
Maria Asimopoulos
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage of famotidine for patients with gastroesophageal reflux disease (GERD) who weigh at least 40 kg?
What is the recommended dosage...
11/18/2022
Pharmacy Learning Network
Quiz
Identifying Preferred H2 Blocker for Treating GERD in Breastfeeding Patients
09/26/2022
Maria Asimopoulos
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor...
09/26/2022
Pharmacy Learning Network
Quiz
Understanding Overnight Symptoms of Heartburn
12/22/2021
Maria Asimopoulos
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have...
12/22/2021
Pharmacy Learning Network
Quiz
Preventing Symptoms of Heartburn
12/22/2021
Maria Asimopoulos
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food...
12/22/2021
Pharmacy Learning Network
Quiz
Identifying Active Ingredients for Treating Heartburn
10/16/2021
Maria Asimopoulos
What kind of active ingredient is famotidine?
What kind of active ingredient is famotidine?
What kind of active ingredient...
10/16/2021
Pharmacy Learning Network
Quiz
Overnight Remedies for Heartburn
10/16/2021
Maria Asimopoulos
True or False: Antacids and H2 blockers both provide stomach acid control through the night.
True or False: Antacids and H2 blockers both provide stomach acid control through the night.
True or False: Antacids and H2...
10/16/2021
Pharmacy Learning Network
Quiz
How to Relieve Heartburn
10/07/2021
Maria Asimopoulos
Can you identify remedies for heartburn from the following list?
Can you identify remedies for heartburn from the following list?
Can you identify remedies for...
10/07/2021
Pharmacy Learning Network
Quiz
Discerning Causes of Heartburn
10/07/2021
Maria Asimopoulos
True or False: Increased pressure on your abdomen from pregnancy can trigger symptoms of heartburn.
True or False: Increased pressure on your abdomen from pregnancy can trigger symptoms of heartburn.
True or False: Increased...
10/07/2021
Pharmacy Learning Network
Quiz
Identifying Heartburn Myths
10/07/2021
Maria Asimopoulos
Which of the following does not help to alleviate heartburn?
Which of the following does not help to alleviate heartburn?
Which of the following does not...
10/07/2021
Pharmacy Learning Network
Quiz
Distinguishing Between Active Ingredients in Heartburn Treatments
09/09/2021
Maria Asimopoulos
True or False: The active ingredient in an H2 blocker is esomeprazole/omeprazole.
True or False: The active ingredient in an H2 blocker is esomeprazole/omeprazole.
True or False: The active...
09/09/2021
Pharmacy Learning Network
Quiz
How New Alabama Law Will Affect Independent Pharmacies
10/22/2025
True or False: Under Alabama’s Community Pharmacy Relief Act (S.B. 252), pharmacy benefit managers (PBMs) must reimburse independent pharmacies at the same rate as Medicaid, which is generally a $10.64 dispensing fee per prescription.
True or False: Under Alabama’s Community Pharmacy Relief Act (S.B. 252), pharmacy benefit managers (PBMs) must reimburse independent pharmacies at the same rate as Medicaid, which is generally a $10.64 dispensing fee per prescription.
True or False: Under Alabama’s...
10/22/2025
Pharmacy Learning Network
Quiz
Lawsuit Against Walgreens Over Religious Accommodations
10/08/2025
True or False: The pharmacists in the lawsuit against Walgreens claim they were denied religious accommodations for both abortion and gender-affirming medications under Minnesota law.
True or False: The pharmacists in the lawsuit against Walgreens claim they were denied religious accommodations for both abortion and gender-affirming medications under Minnesota law.
True or False: The pharmacists...
10/08/2025
Pharmacy Learning Network
Quiz
Pharmacist Sentenced for Animal Cruelty
09/15/2025
Learn more about a pharmacist who was sentenced to prison for using controlled dangerous substances to kill his dog.  
Learn more about a pharmacist who was sentenced to prison for using controlled dangerous substances to kill his dog.  
Learn more about a pharmacist...
09/15/2025
Pharmacy Learning Network
Quiz
New York Executive Order Expands COVID Vaccine Access
09/10/2025
Learn more about a New York executive order that is breaking with FDA restrictions on COVID vaccines to expand access.
Learn more about a New York executive order that is breaking with FDA restrictions on COVID vaccines to expand access.
Learn more about a New York...
09/10/2025
Pharmacy Learning Network
Quiz
Pharmacy Compliance and Controlled Substance Oversight
08/28/2025
Learn more about how pharmacies can maintain compliance with the Controlled Substances Act to avoid legal and financial risk.
Learn more about how pharmacies can maintain compliance with the Controlled Substances Act to avoid legal and financial risk.
Learn more about how pharmacies...
08/28/2025
Pharmacy Learning Network
Quiz
Key Factors in Asthma Wrongful Death Suit
08/21/2025
What was the primary legal issue in the wrongful death case brought by Cole Schmidtknecht’s parents against Optum Rx and Walgreens?
What was the primary legal issue in the wrongful death case brought by Cole Schmidtknecht’s parents against Optum Rx and Walgreens?
What was the primary legal issue...
08/21/2025
Pharmacy Learning Network
Quiz
Assessing Health Care Fraud Damages
07/18/2025
True or False: Between 2013 and 2017, Prime Aid Union City submitted false claims and received over $65 million in reimbursements for medications that were never provided, ordered, or stocked.
True or False: Between 2013 and 2017, Prime Aid Union City submitted false claims and received over $65 million in reimbursements for medications that were never provided, ordered, or stocked.
True or False: Between 2013 and...
07/18/2025
Pharmacy Learning Network
Quiz
Cholinesterase Inhibitors in Alzheimer Disease Treatment
06/12/2025
True or False: Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are disease-modifying therapies that significantly delay the progression of early Alzheimer disease by reducing amyloid-beta accumulation.TrueFalse
True or False: Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are disease-modifying therapies that significantly delay the progression of early Alzheimer disease by reducing amyloid-beta accumulation.TrueFalse
True or False: Cholinesterase...
06/12/2025
Pharmacy Learning Network
Quiz
Alzheimer Disease Treatment Types
05/05/2025
True or False: Donepezil, rivastigmine, and galantamine are all FDA-approved acetylcholinesterase inhibitors indicated for the treatment of mild to severe Alzheimer disease.
True or False: Donepezil, rivastigmine, and galantamine are all FDA-approved acetylcholinesterase inhibitors indicated for the treatment of mild to severe Alzheimer disease.
True or False: Donepezil,...
05/05/2025
Pharmacy Learning Network
Quiz
Mechanism of Action in Alzheimer Disease Medication
04/22/2025
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of...
04/22/2025
Pharmacy Learning Network

Sign Up Today! Enter your email below.

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use